# Durable Medical Equipment Market

> Durable Medical Equipment Market Research Report: Size, Share, Trend Analysis By Device Type (Personal Mobility Devices, Medical Furniture, Monitoring and Therapeutic Devices, And Bathroom Safety Devices), By End Userss (Hospital/Clinic, Ambulatory Surgical Center, Research Centers, And Home Healthcare), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2026-2035
- **CAGR:** 5.80%
- **2025:** USD 246.90 Billion
- **2035:** USD 433.70 Billion
- **Key Players:** ResMed, Baxter International (Hillrom), Medline Industries, Philips, Stryker, Invacare Holdings, Drive DeVilbiss Healthcare, Cardinal Health

**Report ID:** MRFR/MED/1989-HCR · **Pages:** 55 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** September 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/durable-medical-equipment-market-2676

---

## Market Summary

## Durable Medical Equipment Market Summary

The Durable Medical Equipment Market was valued at USD 246.90 billion in 2025 and is projected to open the forecast window at USD 261.10 billion in 2026 before reaching USD 433.70 billion by 2035, advancing at a 5.80% CAGR between 2026 and 2035. Two catalysts anchor that trajectory. The U.S. Centers for Medicare & Medicaid Services extended [acute hospital care](https://www.marketresearchfuture.com/reports/acute-hospital-care-market-4931) at home waiver authority into 2026, keeping roughly 380 participating hospitals eligible to bill inpatient rates for home-delivered acuity [1]. Japan's long-term care insurance system, meanwhile, disburses more than JPY 11 trillion annually, a share of which subsidizes rental beds, lifts and mobility hardware [2].

Legacy equipment fleets are being retired faster than at any point since the 1990s. Analog oxygen concentrators, mechanical hospital beds and unconnected CPAP units are giving way to cellular-enabled hardware that streams adherence and vital-sign telemetry. ResMed reported more than 27 million cloud-connectable devices in the field by 2025, while Abbott shipped over-the-counter continuous glucose sensors that eliminate finger-stick calibration entirely [3][4]. Venture and strategic capital committed roughly USD 6.8 billion to connected home-care hardware and software between 2023 and 2025 [5].

North America holds 43.8% of global revenue, supported by Medicare Part B coverage breadth and dense supplier networks. Asia-Pacific grows fastest at a 9.1% CAGR, propelled by Chinese provincial subsidy pilots and Indian private-insurance expansion. Europe ranks second on revenue, where EU Medical Device Regulation compliance costs have consolidated smaller manufacturers into larger platforms. Through 2035, competitive advantage in the Durable Medical Equipment Market will migrate from hardware margin toward recurring service and analytics revenue.

## Key Report Takeaways

### • By Device Type

- Monitoring and Therapeutic Devices commanded 41.1% of Durable Medical Equipment Market share in 2025, the largest single device category
- [Personal Mobility Devices](https://www.marketresearchfuture.com/reports/personal-mobility-devices-market-11524) generated USD 82.71 billion in 2025 revenue, with wheelchairs forming the deepest sub-category

### • By End-User

- Hospitals and clinics accounted for 57.0% of 2025 revenue, sustained by high-acuity ventilators and imaging platforms
- Home-healthcare settings are expanding at a 10.5% CAGR through 2035, the fastest end-user trajectory in the Durable Medical Equipment Market

### • By Distribution Channel

- Retail pharmacies and DME stores led with 49.7% revenue share in 2025
- Online and direct-to-patient channels are advancing at a 12.6% CAGR to 2035

### • By Region

- North America held 43.8% of the Durable Medical Equipment Market in 2025
- Asia-Pacific posts the highest regional CAGR at 9.1% through 2035
- Europe contributed USD 65.18 billion in 2025 revenue

## Market Size and Forecast (2021–2035)

Estimates combine manufacturer revenue disclosures, Medicare and national-payer claims volumes, customs trade data for device HS codes, and supplier channel checks across 14 countries. Historical values were reconciled against public filings from the ten largest manufacturers; forecast years apply a demand model weighted by population-over-65 growth, reimbursement rate changes, and home-care penetration rates.

## Market Drivers

## Driver Impact Analysis

| Driver | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Aging demographics and chronic disease prevalence | ~1.4 | Global | Long-term (≥4 yr) | [8] |
| Reimbursement expansion for home-based care | ~1.1 | North America, Japan | Medium-term (2–4 yr) | [1] |
| Connected device and remote monitoring adoption | ~0.9 | Global | Medium-term (2–4 yr) | [3] |
| Asia-Pacific public insurance coverage expansion | ~0.8 | Asia-Pacific | Long-term (≥4 yr) | [9] |
| Hospital-at-home and post-acute capacity shifts | ~0.7 | North America, Europe | Short-term (≤2 yr) | [1] |
| E-commerce and direct-to-patient fulfillment | ~0.6 | North America, Europe | Short-term (≤2 yr) | [10] |
| Rental and subscription ownership models | ~0.5 | Global | Medium-term (2–4 yr) | [11] |

### Aging Demographics and Chronic Disease Prevalence

According to UN estimates, the number of people over 65 will increase from 857 million in 2025 to around 1.2 billion by 2035. This group uses equipment at a rate that is four to six times higher per capita than that of working-age adults [8]. According to Medicare data, 68% of beneficiaries manage two or more chronic diseases, each of which increases the need for recurrent devices. The need for bariatric beds and lifts, a category whose average selling prices are 40–55% higher than ordinary equivalents, is further increased by the rising prevalence of obesity. 

### Reimbursement Expansion for Home-Based Care

Payers continue to transfer funds to residential environments. Since its launch, the acute hospital care at home program has covered over 30,000 admissions in the United States, all of which required the placement of beds, monitors, and infusion equipment in patient homes [1]. For 13 types of equipment, Japan's long-term care insurance reimburses rentals rather than purchases, maintaining steady supplier cash flow [2]. In 2024, connected monitoring entries were added to Germany's Hilfsmittelverzeichnis, bringing previously privately funded gadgets under statutory coverage [12].

### Connected Device and Remote Monitoring Adoption

Cellular and Bluetooth modules now cost under USD 9 per unit at volume, making connectivity standard rather than premium. CMS remote physiologic monitoring codes reimburse roughly USD 43 to USD 55 per patient per month, giving providers a direct revenue reason to deploy connected hardware [1]. ResMed's cloud platform has processed over 20 billion nights of therapy data, and adherence programs built on it have lifted compliance rates by 12 to 22 percentage points in published cohorts [3].

### Asia-Pacific Public Insurance Coverage Expansion

China's provincial long-term care insurance pilots now cover 49 cities and approximately 180 million residents, subsidizing beds, mobility aids, and oxygen hardware that households previously self-funded [9]. India's Ayushman Bharat scheme, covering 550 million people, has widened post-acute benefit definitions in several states. Regional manufacturing incentives compound the effect: India's production-linked scheme for medical devices allocated USD 425 million, cutting landed costs for domestically assembled equipment by an estimated 15%.

### Hospital-at-Home and Post-Acute Capacity Shifts

Bed scarcity is doing what policy alone could not. U.S. hospital occupancy averaged 75% through 2025, roughly 11 points above pre-2020 norms, forcing discharge planners to equip homes faster [13]. NHS England's virtual ward programme reached about 12,900 beds capacity, each requiring monitoring kits and oxygen provision [14]. Suppliers that guarantee same-day delivery windows now win preferred-vendor status, converting logistics capability directly into contracted volume across the Durable Medical Equipment Market.

### E-Commerce and Direct-to-Patient Fulfillment

Digital ordering compresses the gap between prescription and possession. Amazon Pharmacy's same-day delivery footprint reaches close to half of U.S. households, and CVS Health embedded equipment ordering inside its mobile application, cutting discharge-to-delivery intervals from days to hours [10]. European sellers operating under ISO 13485 and GDPR now transact cross-border within the single market, and online channels captured an estimated 18.1% of 2025 global revenue.

### Rental and Subscription Ownership Models

Capital-constrained providers increasingly rent. Rental and equipment-as-a-service arrangements represented roughly 21% of 2025 placements by value, up from about 14% in 2021, as suppliers align billing with utilization [11]. Subscription contracts bundling hardware, preventive maintenance, and firmware updates typically carry gross margins 8 to 14 points above outright sale. Baxter and Medline both expanded managed-equipment programs in 2024, locking multi-year revenue against single procurement decisions.

## Restraints

## Restraints Impact Analysis

Restraint impacts are directional drags on the composite growth rate, estimated through pricing and volume sensitivity analysis. They are not additive against the headline CAGR and several overlap in mechanism, particularly reimbursement pressure and administrative burden.

| Restraint | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Competitive bidding and reference pricing compression | ~-0.8 | North America, Europe | Medium-term (2–4 yr) | [1] |
| Component cost and supply chain volatility | ~-0.6 | Global | Short-term (≤2 yr) | [15] |
| Reimbursement documentation and audit burden | ~-0.5 | North America | Medium-term (2–4 yr) | [16] |
| Product recalls and regulatory scrutiny | ~-0.4 | Global | Short-term (≤2 yr) | [7] |
| Service technician and fitting capacity shortages | ~-0.3 | Global | Long-term (≥4 yr) | [17] |

### Competitive Bidding and Reference Pricing Compression

In the past, Medicare's competitive bidding program reduced permissible rates by an average of 45% across all bid categories, and CMS indicated that it intended to start rounds that would cover more product categories [1]. Similar results are obtained from European reference pricing; in 2024, Germany's fixed-amount regulations reduced reimbursement for a number of mobility categories. In response, suppliers lower SKU ranges, which limits income per placement and decreases patient choice. 

### Component Cost and Supply Chain Volatility

Inputs from semiconductors and rare-earth magnets are still constrained. In 2025, the average lead time for electronic components for medical-grade controllers was still 22 weeks, which was significantly longer than the baseline of 12 weeks prior to 2020 [15]. Frame-intensive items like beds and walkers were most severely impacted by price variations of 18% year over year in aluminium and stainless steel, which suppliers under fixed-rate payment contracts are unable to pass through.

### Reimbursement Documentation and Audit Burden

Paperwork consumes margin. U.S. suppliers face claim denial rates near 17% for certain equipment categories, and Comprehensive Error Rate Testing found improper payment rates above 25% in prior review cycles for selected items [16]. Each appealed claim costs an estimated USD 43 in administrative labour. Smaller regional suppliers, lacking dedicated billing teams, exit categories rather than absorb the compliance overhead.

### Product Recalls and Regulatory Scrutiny

The Philips Respironics recall touched more than 5.5 million sleep and respiratory devices and triggered a consent decree restricting U.S. sales, reshaping competitive share across the category [7]. Regulators have since tightened post-market surveillance expectations under EU MDR and FDA guidance. Heightened scrutiny lengthens clearance timelines by an estimated three to six months for connected respiratory and monitoring products.

### Service Technician and Fitting Capacity Shortages

Complex products need trained hands. Custom seating and power-chair fittings require certified assistive technology professionals, a workforce numbering only in the low thousands across North America, and vacancy rates for equipment service roles exceeded 14% in 2025 [17]. Fitting backlogs of six to ten weeks in some U.S. states delay revenue recognition and push patients toward simpler, lower-value alternatives.

## Opportunities

## Durable Medical Equipment Market Opportunities

### Device Telemetry as a Recurring Revenue Stream

Equipment that reports adherence, usage hours, and fault codes generates data payers will pay for. Vendors monetizing telemetry through per-patient-per-month analytics subscriptions report attach rates of 30–40% on connected respiratory fleets, adding USD 6 to USD 15 monthly per device at software-level margins. Building validated outcome evidence is the gating factor, since payers fund analytics only when readmission or adherence improvements are demonstrable.

### Emerging-Market Coverage Gaps

Penetration remains thin where demand is rising fastest. India, Indonesia and Vietnam together host over 180 million people aged 60 and above but consume equipment at roughly one-eighth the per-capita rate of Western Europe. Localized manufacturing, ruggedized designs tolerant of unstable power, and rental pricing under USD 20 monthly unlock this base. Suppliers pairing distribution with state insurance panels capture volume ahead of incumbents.

### Equipment-as-a-Service Contracting

Health systems increasingly prefer operating expenditure over capital outlay. Managed-equipment agreements bundling hardware, consumables, maintenance and replacement across five to seven years shift procurement conversations from unit price to guaranteed uptime. Vendors capable of underwriting availability commitments of 98% or better command premium pricing and materially longer customer tenure, insulating them from the bidding compression documented earlier.

### Refurbishment and Circular Equipment Programs

Sustainability requirements are becoming procurement criteria. NHS Supply Chain and several European systems now weight lifecycle carbon in tender scoring, and refurbished beds and mobility hardware can carry 35–50% lower embodied emissions than new units at 40–60% of the price. Certified refurbishment lines also give suppliers a second margin cycle on returned rental fleets, improving asset economics within the Durable Medical Equipment Market.

### Retail-Clinic Convergence

Pharmacies retain a defensible position where physical fitting matters. In-store assessment clinics offering same-day walker sizing, oxygen setup, and mask fitting convert foot traffic into reimbursable service encounters that pure e-commerce cannot replicate. Chains combining a retail footprint with four-hour delivery partnerships defend share against digital entrants while capturing incremental service fees.

## Future Outlook

## Durable Medical Equipment Market Future Outlook

### Predictive Maintenance and Embedded Intelligence

Algorithms will decide when equipment gets serviced, not calendars. Fleet operators applying failure-prediction models to ventilators and concentrators report unplanned downtime reductions of 25–35% and service-visit cost savings near USD 90 per avoided call-out. By 2030, expect predictive diagnostics to ship as default firmware on mid-tier hardware rather than as a premium module. Vendors lacking installed-base telemetry will struggle to price service contracts competitively, a structural disadvantage inside the Durable Medical Equipment Market.

### Platform Economics and Subscription Pricing

Revenue models are decoupling from unit shipments. Subscription and utilization-based billing could represent 30–35% of supplier revenue by 2035, up from roughly 21% today, changing how investors value the sector toward recurring-revenue multiples. Manufacturers are acquiring niche analytics firms to secure the software layer, and channel partners increasingly earn margin on managed services rather than hardware markup. Cash-flow smoothing matters most to mid-market suppliers exposed to bidding volatility.

### Interoperability and Data Standards

Fragmented device data is the main barrier to payer-funded remote monitoring at scale. Adoption of HL7 FHIR and IEEE 11073 device profiles is accelerating, with major electronic health record vendors expanding device-ingestion APIs [20]. Regulators are following: the European Health Data Space regulation sets phased obligations for structured health data exchange through the early 2030s. Devices that cannot write structured observations into a patient record will be excluded from value-based contracts.

### Sustainability and Circular Product Design

Procurement scoring is starting to price carbon. Healthcare accounts for roughly 4.4% of global net emissions, and NHS England targets net zero for its directly controlled emissions by 2040, with supplier carbon disclosure already a tender condition [21]. Manufacturers are redesigning for disassembly, extending battery service life and standing up certified refurbishment lines. Suppliers publishing verified lifecycle assessments will win framework agreements that competitors cannot bid on.

## Segment Insights

## Durable Medical Equipment Market Segmentation

### By Device Type

| Segment | Metric | Primary Demand Driver |
| --- | --- | --- |
| Monitoring & Therapeutic Devices | 41.1% share (2025) | Remote monitoring reimbursement and OTC sensor launches |
| Personal Mobility Devices | USD 82.71 billion (2025) | Aging population and rehabilitation coverage |
| Bathroom Safety Devices & Medical Furniture | 4.2% CAGR (2026–2035) | Fall-prevention programs and home modification funding |

Monitoring and therapeutic devices lead the Durable Medical Equipment Market on both share and momentum, carried by connected CPAP systems, oxygen concentrators, and continuous glucose sensors that now reimburse through remote monitoring codes [3][4]. Personal mobility devices remain the second-largest pool, with wheelchairs forming the deepest sub-category and power models adding fall-detection sensors to justify premium pricing. Bathroom safety devices and medical furniture grow slowest, since low unit prices and long replacement cycles cap revenue expansion despite steady placement volumes.

### By End-User

| Segment | Metric | Primary Demand Driver |
| --- | --- | --- |
| Hospitals & Clinics | 57.0% share (2025) | High-acuity ventilators, beds, and imaging platforms |
| Home-Healthcare Settings | 10.5% CAGR (2026–2035) | Reimbursement migration to residential care |
| Ambulatory Surgery Centers | USD 27.16 billion (2025) | Same-day procedure volume growth |
| Nursing Homes & Hospices | 7.2% share (2025) | Readmission-penalty avoidance |

Hospitals and clinics still buy most of the equipment, anchored by intensive-care ventilators and high-acuity beds that residential settings cannot absorb. Home-healthcare settings grow more than twice as fast, because payers in the United States and Japan now fund acute-grade care outside facility walls [1][2]. Ambulatory surgery centers add steady demand for mobile C-arms and compact ultrasound, while nursing homes and hospices procure connected beds and monitoring mats to detect deterioration before it triggers a penalized readmission.

### By Distribution Channel

| Segment | Metric | Primary Demand Driver |
| --- | --- | --- |
| Retail Pharmacies & DME Stores | 49.7% share (2025) | Fitting services and same-day pickup |
| Hospital & Clinic Pharmacies | USD 79.53 billion (2025) | Discharge-linked equipment provisioning |
| Online & Direct-to-Patient | 12.6% CAGR (2026–2035) | E-commerce fulfillment and consumer self-pay |

Retail pharmacies and DME stores hold the largest channel position because custom seating, mask fitting, and oxygen setup still require physical assessment. Hospital and clinic pharmacies capture substantial value at discharge, where speed determines whether a bed is freed the same day. Online and direct-to-patient channels grow fastest by a wide margin, driven by same-day delivery partnerships and consumer self-pay for simpler categories, though high-touch products resist migration and keep the physical channel structurally relevant across the Durable Medical Equipment Market.

## Regional Market Share Analysis

## Regional Market Share Analysis

| Region | Key Metric (2025 / 2026–2035) | Primary Investment Themes |
| --- | --- | --- |
| North America | 43.8% revenue share | Hospital-at-home, connected respiratory, rental fleets |
| Europe | USD 65.18 billion | MDR compliance, circular procurement, statutory coverage |
| Asia-Pacific | 9.1% CAGR | Public insurance pilots, local manufacturing, mobility aids |
| South America | USD 12.84 billion | Private hospital build-out, distributor consolidation |
| Middle East & Africa | 4.1% revenue share | Sovereign health infrastructure, rehabilitation capacity |
| Total | 100.0% / USD 246.90 billion | — |

### North America

| Country | Metric | Key Driver |
| --- | --- | --- |
| United States | 88.5% of regional revenue | Medicare Part B coverage breadth |
| Canada | USD 12.44 billion | Provincial assistive device programs |

American demand rests on the widest reimbursement base in the world, though the terms keep tightening. CMS coverage spans oxygen, mobility, respiratory, and support-surface categories, while the hospital-at-home waiver keeps acute-grade hardware flowing into residences [1]. Canadian provinces run separate assistive device programs, with Ontario's covering up to 75% of approved equipment cost, producing steadier but lower-margin volume. Consolidation among U.S. suppliers continues, with the top five accounting for a growing slice of the Durable Medical Equipment Market in the region.

### Europe

| Country | Metric | Key Driver |
| --- | --- | --- |
| Germany | 24.6% of regional revenue | Statutory aids directory listings |
| United Kingdom | USD 11.40 billion | NHS virtual ward expansion |
| France | 5.1% CAGR | Home hospitalization reimbursement |
| Rest of Europe | 31.2% of regional revenue | Nordic and Southern procurement frameworks |

European growth is regulatory before it is commercial. EU Medical Device Regulation transition costs have pushed an estimated 10–14% of smaller manufacturers to withdraw legacy SKUs, concentrating volume among firms able to fund clinical evidence packages [12]. NHS England's virtual ward build-out created immediate demand for monitoring kits and home oxygen therapy devices, while France's hospitalisation à domicile framework reimburses residential acute care at defined tariffs. Circular procurement scoring now shapes tender outcomes across Nordic systems.

### Asia-Pacific

| Country | Metric | Key Driver |
| --- | --- | --- |
| China | 31.4% of regional revenue | Provincial long-term care insurance pilots |
| Japan | USD 13.16 billion | Long-term care insurance rental model |
| India | 11.9% CAGR | Private insurance and domestic manufacturing incentives |
| Rest of Asia-Pacific | 22.8% of regional revenue | Australian and Korean aged-care funding |

Growth here compounds from a low base against extraordinary demographic pressure. Japan already has 29% of its population over 65 and channels long-term care insurance toward rental rather than ownership, giving suppliers annuity-like revenue [2]. China's 49-city insurance pilots normalize hospital-grade beds in apartments, and domestic manufacturers now undercut imports by 25–35% on mobility categories [9]. Indian demand is accelerating fastest, supported by manufacturing incentives that reduce landed costs materially.

### South America

| Country | Metric | Key Driver |
| --- | --- | --- |
| Brazil | 54.6% of regional revenue | Private hospital network expansion |
| Rest of South America | USD 5.83 billion | Public tender modernization |

Brazilian private health operators added roughly 9,000 beds between 2022 and 2025, each requiring support surfaces, mobility hardware and monitoring equipment [18]. ANVISA registration timelines averaging 9 to 14 months slow foreign entrants, favouring distributors with local regulatory teams. Currency volatility remains the dominant commercial risk, prompting suppliers to price in dollars and finance through local leasing partners. Chilean and Colombian public tenders increasingly bundle multi-year service commitments alongside hardware supply.

### Middle East & Africa

| Country | Metric | Key Driver |
| --- | --- | --- |
| Saudi Arabia | 21.3% of regional revenue | Health Sector Transformation Program |
| United Arab Emirates | USD 1.94 billion | Mandatory insurance coverage breadth |
| South Africa | 6.4% CAGR | Rehabilitation and chronic care capacity |
| Rest of Middle East & Africa | 48.9% of regional revenue | Donor-funded equipment programs |

Gulf spending is policy-led and lumpy. Saudi Arabia's Health Sector Transformation Program targets privatization of a substantial share of hospital capacity, and new facilities specify connected equipment from commissioning [19]. Emirati mandatory insurance covers home nursing and associated hardware in Dubai and Abu Dhabi, lifting per-capita consumption well above regional norms. African demand concentrates in South Africa and Kenya, where rehabilitation capacity gaps and donor-funded procurement shape purchasing far more than private insurance does.

## Competitive Benchmarking

## Competitive Benchmarking

Concentration sits in the medium band. The estimated Herfindahl-Hirschman Index for the global Durable Medical Equipment Market falls between 600 and 750, with the top five suppliers holding roughly 34–40% of revenue. The remainder is highly fragmented across regional distributors, specialist fitters, and category manufacturers, particularly in mobility and bathroom safety where local service capability outweighs brand. Consolidation is accelerating through acquisitions of analytics firms and regional rental fleets rather than horizontal hardware mergers.

| Company | Est. Revenue Share Range | Key Offerings for Durable Medical Equipment Market | Strategic Positioning |
| --- | --- | --- | --- |
| ResMed | ~7–9% | CPAP and bilevel systems, cloud adherence platform | Category leader in connected sleep and respiratory therapy |
| Baxter International (Hillrom) | ~6–8% | Hospital beds, support surfaces, vital-sign monitoring | Facility-first portfolio with managed-equipment contracting |
| Medline Industries | ~5–7% | Mobility aids, bathroom safety, medical furniture | Distribution scale and private-label breadth |
| Philips | ~5–7% | Respiratory therapy, monitoring, home ventilation | Rebuilding respiratory position post-remediation |
| Stryker | ~4–6% | Patient handling, stretchers, specialty support surfaces | Premium acute-care hardware with service depth |
| Invacare Holdings | ~3–5% | Wheelchairs, power mobility, respiratory products | Mobility specialist with European manufacturing base |
| Drive DeVilbiss Healthcare | ~3–5% | Mobility, respiratory, sleep and bath safety | Broad mid-price portfolio across retail channels |
| Cardinal Health | ~3–4% | Home care consumables and equipment distribution | Channel intermediary with hospital-to-home reach |
| Sunrise Medical | ~2–4% | Manual and power wheelchairs, custom seating | Custom mobility and configuration expertise |
| Permobil | ~2–3% | Power wheelchairs, seating, positioning systems | Complex rehab technology and clinical outcome focus |
| Ottobock | ~2–3% | Mobility, seating, rehabilitation equipment | Rehabilitation-led portfolio with strong EU presence |

## Recent News & Developments

## Recent News & Developments

- Philips (January 2024): Entered a consent decree with the FDA restricting U.S. sleep and respiratory device sales pending remediation, redistributing several points of category share to competitors [7]
- Abbott (September 2024): Launched an over-the-counter continuous glucose sensor in the United States, expanding the addressable base beyond prescription diabetes management [4]
- CMS (December 2024): Congressional action extended acute hospital care at home waiver authority, preserving reimbursement for residential acute equipment placement into 2026 [1]
- Baxter (March 2025): Expanded managed-equipment service agreements across North American health systems, bundling beds, surfaces and maintenance under multi-year availability commitments [11]
- ResMed (May 2025): Reported surpassing 27 million cloud-connectable devices in the field and expanded remote adherence analytics for payer programs [3]
- NHS England (June 2025): Scaled virtual ward capacity toward approximately 12,900 beds, driving procurement of home monitoring kits and oxygen provision [14]
- Medline (August 2025): Announced additional U.S. distribution capacity to support four-hour metropolitan fulfillment commitments with retail and delivery partners [10]
- Sunrise Medical (October 2025): Acquired a European custom-seating specialist to deepen complex rehabilitation configuration capability and shorten fitting lead times [22]

## Report Scope

| Parameter | Detail |
| --- | --- |
| Market Scope | Global durable patient care equipment across device type, end-user and distribution channel |
| Study Period | 2021–2035 (Historical 2021–2024; Base Year 2025; Forecast 2026–2035) |
| CAGR | 5.80% (2026–2035) |
| Market Size Checkpoints | USD 246.90 billion (2025); USD 261.10 billion (2026); USD 433.70 billion (2035) |
| Fastest Growing Segments | Online & Direct-to-Patient (12.6% CAGR); Home-Healthcare Settings (10.5% CAGR); Asia-Pacific (9.1% CAGR) |
| Companies Profiled | ResMed, Baxter International, Medline Industries, Philips, Stryker, Invacare Holdings, Drive DeVilbiss Healthcare, Cardinal Health, Sunrise Medical, Permobil, Ottobock |
| Valuation Currency | USD Billion, constant 2025 exchange rates |

## Frequently Asked Questions

**Q: How should procurement teams evaluate total cost of ownership in the Durable Medical Equipment Market?**
A: Model service contracts, consumable replacement, and downtime separately from acquisition price. Connected fleets typically shift 30–40% of lifetime cost into recurring service, so uptime guarantees matter more than unit discounts [11].

**Q: When does renting equipment beat purchasing outright?**
A: Renting wins when utilization runs below roughly 60% or when reimbursement itself is rental-based, as in Japan. Purchase makes sense for high-turn, low-complexity items with predictable demand [2].

**Q: Which certifications matter most for vendors entering the Durable Medical Equipment Market?**
A: ISO 13485 quality certification and EU MDR conformity are baseline for European access. FDA 510(k) clearance governs most U.S. device categories, while IEC 60601 electrical safety applies to powered equipment [12].

**Q: How do cybersecurity requirements affect connected device deployment?**
A: FDA premarket submissions now require a software bill of materials and coordinated vulnerability disclosure plans. Hospitals increasingly reject devices lacking documented patch pathways, adding three to six months to procurement cycles [7].

**Q: What integration problems arise when linking devices to electronic health records?**
A: Proprietary data formats remain the main obstacle. Devices emitting HL7 FHIR observations integrate in weeks; those requiring custom middleware often take six months and incur ongoing interface maintenance costs [20].

**Q: Where are private-equity investors concentrating capital in the Durable Medical Equipment Market?**
A: Regional rental fleets and complex rehabilitation fitting networks attract the most interest, because recurring billing and licensed-technician scarcity create defensible positions. Pure hardware manufacturing draws less capital [5].

**Q: How do tariffs and localization rules reshape sourcing decisions?**
A: India's production-linked incentives and Chinese domestic procurement preferences push manufacturers toward in-region assembly. Suppliers report landed-cost swings of 15–25% depending on where final assembly occurs [9].


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/durable-medical-equipment-market-2676*